Kopp Investment Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Kopp Investment Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2.85M	Sell	104,462 -57,680	-36%	-$1.49M	5.23%	6
2019 Q2	$3.9M	Sell	162,142 -40,385	-20%	-$1.02M	4.44%	9
2019 Q1	$5.35M	Buy	202,527 +56,176	+38%	+$1.33M	4.33%	7
2018 Q4	$2.86M	Buy	146,351 +54,162	+59%	+$1.06M	2.79%	16
2018 Q3	$1.8M	Sell	92,189 -1,031	-1%	-$19.6K	1.52%	23
2018 Q2	$1.54M	Sell	93,220 -7,807	-8%	-$119K	1.45%	24
2018 Q1	$1.44M	Sell	101,027 -4,099	-4%	-$60.6K	1.46%	25
2017 Q4	$1.53M	Sell	105,126 -6,389	-6%	-$89.7K	1.54%	25
2017 Q3	$1.41M	Buy	111,515 +89,380	+404%	+$1.14M	1.3%	28
2017 Q2	$263K	Buy	+22,135	New	+$275K	0.24%	54

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Kopp Investment Advisors's HZNP Position: Q3 2019 in Review

Kopp Investment Advisors reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 36% in Q3 2019, selling an estimated $1.49M and leaving 104,462 shares worth $2.85M. The position accounts for 5.23% of the portfolio, ranked #6.

Kopp Investment Advisors first reported a position in HZNP in Q2 2017 and has held it in 10 quarters since. The position peaked at $5.35M in Q1 2019. 264 funds tracked by Wall St. Rank hold HZNP as of Q3 2019.

Kopp Investment Advisors held 104,462 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $2.85M as of Q3 2019.
Kopp Investment Advisors sold 57,680 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2019, an estimated $1.49M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 5.23% of Kopp Investment Advisors's portfolio in Q3 2019, its #6 holding.
Kopp Investment Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and has held it in 10 quarters since.
Kopp Investment Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.35M in Q1 2019.
264 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2019.

Based on Kopp Investment Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.